Luye Pharma Group Ltd. (HKG:2186)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.730
-0.035 (-1.98%)
Oct 9, 2026, 4:08 PM HKT

Luye Pharma Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
696.36618.75471.89532.61604.81-134.39
Depreciation & Amortization
858.53835.13783.39693.73663.46577
Other Amortization
4.364.367.288.127.864.99
Loss (Gain) From Sale of Assets
3.434.96-18.49-1.50.21-11.36
Asset Writedown & Restructuring Costs
----11.47-
Loss (Gain) From Sale of Investments
-12.327.73-1.79-1.94-1.5514.81
Loss (Gain) on Equity Investments
35.731.570.77-0.79-0.83-10.27
Stock-Based Compensation
10.7613.3721.520.6425.4549.98
Other Operating Activities
-345.818.26136.97-53.3723.14109.71
Change in Accounts Receivable
-120.06-479.1-424.88-570.84-18.77-211.76
Change in Inventory
-236.75-44.65-84.03-54.92-26.6-134.04
Change in Accounts Payable
373.27463.94-77.89207.24-10.9543.64
Change in Unearned Revenue
126.35157.499.97-74.87-42.47-6.43
Change in Other Net Operating Assets
-953.6151.36-656.92891.38418.57-109.49
Operating Cash Flow
440.221,783167.761,5951,654182.37
Operating Cash Flow Growth
-81.24%962.89%-89.48%-3.53%806.83%-82.35%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-511.4-511.4-594.07-632.66-655.68-556.2
Sale of Property, Plant & Equipment
2.31.787.443.175.6613.77
Divestitures
---0.02---
Sale (Purchase) of Intangibles
-491.13-491.13-1,113-532.61-507.68-985.4
Investment in Securities
-1,627-2,912536.35-511.14-675.93-2,057
Other Investing Activities
895.99304.3162.36254.97175.32148.46
Investing Cash Flow
-2,110-3,986-1,471-1,418-1,658-3,436

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---4.9610.1-
Long-Term Debt Issued
-10,03110,1198,0777,6567,155
Total Debt Issued
10,63610,03110,1198,0827,6667,155
Short-Term Debt Repaid
----15.06--
Long-Term Debt Repaid
--10,308-8,263-8,555-8,323-7,561
Lease Payments
-29.93-23.76-20.46-23.52-20.64-24.68
Total Debt Repaid
-9,338-10,308-8,263-8,570-8,323-7,561
Net Debt Issued (Repaid)
1,298-276.531,856-488.07-656.23-406.32
Issuance of Common Stock
---922.97-1,044
Other Financing Activities
329.551,0261,101406.7710.381,241
Financing Cash Flow
2,6661,7872,956841.654.151,879

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
282.95-29.7745.41-103.6-164.15-52.37
Net Cash Flow
1,280-445.611,698915.23-114.51-1,427

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-71.181,272-426.31962.83998.11-373.83
Free Cash Flow Growth
----3.54%--
Free Cash Flow Margin
-1.16%20.16%-7.03%15.67%16.69%-7.19%
Free Cash Flow Per Share
-0.020.33-0.110.260.29-0.11
Levered Free Cash Flow
-818.76-692.81-2,501629.06-43-778.54
Unlevered Free Cash Flow
-411-263.69-2,1501,051251.85-528.88
Free Cash Flow After Leases
-101.11,248-446.76939.32977.48-398.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
533.72505.68450.1471.51369.2297.12
Cash Income Tax Paid
209.18191.41206.93132.2392.77270.74
Change in Working Capital
-810.79249.03-1,234397.99319.79-418.08